Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen + Caffeine vs Ibuprofen for Headache Attacks
NCT01172405Phase 3Unknown
- Sponsor
- Mantecorp Farmasa
- Start
- Oct 2010
- Primary completion
- Oct 2012
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of caffeine in tension-type headache (TTH) and migraine (2 arms), sponsored by Mantecorp Farmasa. Primary endpoint: Efficacy of study treatment compared with control to relieve headache symptoms at 4 weeks. Status: unknown.
02
Drugs
caffeine
03
Conditions
tension-type headache (TTH)migraine
Beyond the preview
Go deeper on NCT01172405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01172405.